NCT01244724 - Lexapro for Major Depression in Patients With Epilepsy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

March 31, 2012

Conditions

Major DepressionEpilepsy

Interventions

DRUG

Lexapro

Escitalopram will begin at 10mg. a day. Visits will occur biweekly for 12 weeks. Subjects with minimal or no response and minimal or no side effects after 4 weeks will have the dose increased to 20mg. a day. The maximum dose of escitalopram will not exceed the FDA-approved maximum dose of 20 mg per day.

Trial Locations (1)

10065

Weill Medical College of Cornell University, New York